CB
Chandra Balireddy Kotthapalli
About Chandra Balireddy Kotthapalli
Data last updated:
Chandra Balireddy Kotthapalli is an Additional Director at Shreegen Pharma Limited (since 2025) and Managing Director at Aqzen Impex Private Limited (since 2019). The companies operate in Pharma and Consumer Goods. The 2 current companies with reported revenue have a combined latest revenue of ₹16.19 Cr; the largest is Shreegen Pharma Limited at ₹9.20 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 14 May 2025 | 2012 | ₹9.20 Cr (FY 2023) | Active | |
| Managing Director | 14 Jan 2019 | 2019 | ₹6.99 Cr (FY 2025) | Active |
Board colleagues of Chandra Balireddy Kotthapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kanaka Nallamilli Sundara Reddy | 07523776 | Shreegen Pharma Limited | Director |
| Rajeev Dinesh Srivastava | 07861590 | Shreegen Pharma Limited | Additional Director |
| Rama Mangeswar Reddy Bobbiti | 03468091 | Shreegen Pharma Limited | Managing Director |
| Sishtla Ramakrishnan | 07955919 | Shreegen Pharma Limited | Director |
| Srinivasa Reddy Daka | 05335763 | Shreegen Pharma Limited | Director |
| Venkata Suryanarayana Reddy Chilukuri | Shreegen Pharma Limited | Cfo | |
| Umamaheswari Devi Kotthapalli | 08446415 | Aqzen Impex Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandra Balireddy Kotthapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandra Balireddy Kotthapalli
Chandra Balireddy Kotthapalli currently holds 2 directorships: Shreegen Pharma Limited (Additional Director, since 14 May 2025, revenue ₹9.20 Cr (FY 2023)); Aqzen Impex Private Limited (Managing Director, since 14 Jan 2019, revenue ₹6.99 Cr (FY 2025)).
Chandra Balireddy Kotthapalli was first appointed on 14 Jan 2019 as Managing Director at Aqzen Impex Private Limited. The most recent appointment on record is 14 May 2025 at Shreegen Pharma Limited.
The 2 current companies of Chandra Balireddy Kotthapalli that report revenue have a combined latest revenue of ₹16.19 Cr: Shreegen Pharma Limited ₹9.20 Cr (FY 2023); Aqzen Impex Private Limited ₹6.99 Cr (FY 2025).
The current boards of Chandra Balireddy Kotthapalli's companies include Kanaka Nallamilli Sundara Reddy (Shreegen Pharma Limited), Rajeev Dinesh Srivastava (Shreegen Pharma Limited), Rama Mangeswar Reddy Bobbiti (Shreegen Pharma Limited), Sishtla Ramakrishnan (Shreegen Pharma Limited), Srinivasa Reddy Daka (Shreegen Pharma Limited), Venkata Suryanarayana Reddy Chilukuri (Shreegen Pharma Limited), among others.